Search Results - "Hatron, P"

Short‐term and long‐term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients by Marie, I., Hatron, P. Y., Dominique, S., Cherin, P., Mouthon, L., Menard, J.‐F.

“…Objective This study was undertaken to assess the characteristics and outcome of interstitial lung disease (ILD) in polymyositis/dermatomyositis (PM/DM) and to…”
Get full text

Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross‐over controlled trial in a rare disease by Gaillard, S., Dupuis‐Girod, S., Boutitie, F., Rivière, S., Morinière, S., Hatron, P.‐Y., Manfredi, G., Kaminsky, P., Capitaine, A.‐L., Roy, P., Gueyffier, F., Plauchu, H.

“…Summary Background Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder associated with abnormal angiogenesis and disabling epistaxis. Tranexamic…”
Get full text

Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis by Marie, I., Antonietti, M., Houivet, E., Hachulla, E., Maunoury, V., Bienvenu, B., Viennot, S., Smail, A., Duhaut, P., Dupas, J ‐L., Dominique, S., Hatron, P.‐Y., Levesque, H., Benichou, J., Ducrotté, P.

“…Summary Background To date, there are no large studies on videocapsule endoscopy in systemic sclerosis (SSc). Consequently, the prevalence and features of…”
Get full text

Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients by Hachulla, A-L, Launay, D, Gaxotte, V, de Groote, P, Lamblin, N, Devos, P, Hatron, P-Y, Beregi, J-P, Hachulla, E

“…To assess the prevalence and patterns of cardiac abnormalities as detected by cardiac magnetic resonance imaging (MRI) in systemic sclerosis (SSc). Fifty-two…”
Get more information

Diagnosis of primary antibody and complement deficiencies in young adults after a first invasive bacterial infection by Sanges, S., Wallet, F., Blondiaux, N., Theis, D., Vérin, I., Vachée, A., Dessein, R., Faure, K., Viget, N., Senneville, E., Leroy, O., Maury, F., Just, N., Poissy, J., Mathieu, D., Prévotat, A., Chenivesse, C., Scherpereel, A., Smith, G., Lopez, B., Rosain, J., Frémeaux-Bacchi, V., Hachulla, E., Hatron, P.-Y., Bahuaud, M., Batteux, F., Launay, D., Labalette, M., Lefèvre, G.

“…Screening for primary immunodeficiencies (PIDs) in adults is recommended after two severe bacterial infections. We aimed to evaluate if screening should be…”
Get full text

Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry by Mekinian, A, Ravaud, P, Hatron, P Y, Larroche, C, Leone, J, Gombert, B, Hamidou, M, Cantagrel, A, Marcelli, C, Rist, S, Breban, M, Launay, D, Fain, O, Gottenberg, J E, Mariette, X

“…To evaluate rituximab (RTX) in primary Sjögren's syndrome (pSS) with peripheral nervous system (PNS) involvement. Patients with pSS and PNS involvement who…”
Get more information

Role of B cells in the pathogenesis of systemic sclerosis by Sanges, S., Guerrier, T., Launay, D., Lefèvre, G., Labalette, M., Forestier, A., Sobanski, V., Corli, J., Hauspie, C., Jendoubi, M., Yakoub-Agha, I., Hatron, P.-Y., Hachulla, E., Dubucquoi, S.

“…Systemic sclerosis (SSc) is an orphan disease characterized by progressive fibrosis of the skin and internal organs. Aside from vasculopathy and fibrotic…”
Get full text

Interstitial Lung Disease in Anti–Jo‐1 Patients With Antisynthetase Syndrome by Marie, I., Josse, S., Hatron, P. Y., Dominique, S., Hachulla, E., Janvresse, A., Cherin, P., Mouthon, L., Vittecoq, O., Menard, J.‐F., Jouen, F.

“…Objective To assess the outcome of interstitial lung disease (ILD) in anti–Jo‐1 patients with antisynthetase syndrome, determine predictive variables of ILD…”
Get full text

Intravenous immunoglobulins for steroid‐refractory esophageal involvement related to polymyositis and dermatomyositis: A series of 73 patients by Marie, I., Menard, J.‐F., Hatron, P. Y., Hachulla, E., Mouthon, L., Tiev, K., Ducrotte, P., Cherin, P.

“…Objective To assess the long‐term outcome of esophageal complications in the group of patients receiving intravenous immunoglobulins (IVIG) for the treatment…”
Get full text

Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome by Marie, I, Josse, S, Decaux, O, Dominique, S, Diot, E, Landron, C, Roblot, P, Jouneau, S, Hatron, P.Y, Tiev, K.P, Vittecoq, O, Noel, D, Mouthon, L, Menard, J.-F, Jouen, F

“…Abstract The aims of the present study were to: compare the characteristics between antisynthetase syndrome (ASS) patients with anti-Jo1 antibody and those…”
Get full text

Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity by Yelnik, C M, Urbanski, G, Drumez, E, Sobanski, V, Maillard, H, Lanteri, A, Morell-Dubois, S, Caron, C, Dubucquoi, S, Launay, D, Duhamel, A, Hachulla, E, Hatron, P Y, Lambert, M

“…Introduction The long-term risk of first thrombosis and benefit of prophylaxis in antiphospholipid antibody (aPL) carriers without history of thrombosis or…”
Get full text

Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome by Yelnik, C M, Lambert, M, Drumez, E, Le Guern, V, Bacri, J-L, Guerra, M M, Laskin, C A, Branch, D W, Sammaritano, L R, Morel, N, Guettrot-Imbert, G, Launay, D, Hachulla, E, Hatron, P-Y, Salmon, J E, Costedoat-Chalumeau, N

“…Purpose The purpose of this study was to evaluate the safety of antithrombotic treatments prescribed during pregnancy in patients with antiphospholipid…”
Get full text

Diffuse calcinosis cutis in systemic lupus erythematosus: an exceptional complication by Soudet, S, Delaporte, E, Hatron, P Y

Get full text

Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics by ROCHE-LESTIENNE, C, LEPERS, S, DIB, M, PHILIPPE, N, CAMBIER, N, BARETE, S, LIBERSA, C, BLETRY, O, HATRON, P.-Y, QUESNEL, B, ROSE, C, MALOUM, K, SOENEN-CORNU, V, BLANCHET, O, FENAUX, P, PRIN, L, PREUDHOMME, C, KAHN, J.-E, LAI, J.-L, HACHULLA, E, DRUPT, F, DEMARTY, A.-L, ROUMIER, A.-S, GARDEMBAS, M

“…Idiopathic hypereosinophilic syndrome (HES) characterized by unexplained and persistent hypereosinophilia is heterogeneous and comprises several entities: a…”
Get full text

Stressful life events and pemphigus by Morell-Dubois, S, Carpentier, O, Cottencin, O, Queyrel, V, Hachulla, E, Hatron, P-Y, Delaporte, E

“…Stress might be a triggering factor causing pemphigus. We studied 11 consecutive cases of pemphigus over 5 years. Studying and looking for a link between…”
Get more information

European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient‐Reported Index: A Complete Picture of Primary Sjögren's Syndrome Patients by Seror, R., Gottenberg, J. E., Devauchelle‐Pensec, V., Dubost, J. J., Le Guern, V., Hayem, G., Fauchais, A.‐L., Goeb, V., Hachulla, E., Hatron, P. Y., Larroche, C., Morel, J., Pedriger, A., Puechal, X., Rist, S., Saraux, A., Sene, D., Sibilia, J., Vittecoq, O., Zarnitsky, C., Labetoulle, M., Ravaud, P., Mariette, X.

“…Objective The European League Against Rheumatism (EULAR) Sjögren's Syndrome (SS) Disease Activity Index (ESSDAI) and the EULAR SS Patient‐Reported Index…”
Get full text

Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease by Fauchais, A L, Martel, C, Gondran, G, Lambert, M, Launay, D, Jauberteau, M O, Hachulla, E, Vidal, E, Hatron, P Y

“…To study evolution of pSS immunological profile, impact on pSS activity and the long-term evolution of patients with atypical auto-antibodies in a bicentric…”
Get full text

Interstitial lung disease in polymyositis and dermatomyositis by Marie, I., Hachulla, E., Chérin, P., Dominique, S., Hatron, P.‐Y., Hellot, M.‐F., Devulder, B., Herson, S., Levesque, H., Courtois, H.

“…Objectives To assess prevalence, characteristics, and long‐term outcome of interstitial lung disease (ILD) in polymyositis (PM) and dermatomyositis (DM). To…”
Get full text

Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis by MARIE, Isabelle, HACHULLA, Eric, HATRON, Pierre-Yves, HELLOT, Marie-France, LEVESQUE, Herve, DEVULDER, Bernard, COURTOIS, Hubert

“…OBJECTIVE: To assess short term and longterm outcome of polymyositis (PM) and dermatomyositis (DM), and predictive variables of PM/DM course. METHODS: The…”
Get full text

Long term use of metformin in idiopathic cyclic edema, report of thirteen cases and review of the literature by Soudet, S., Lambert, M., Lefèvre, G., Maillard, H., Huglo, D., Hatron, P.Y.

“…[Display omitted] Idiopathic cyclic edema (ICE) is a rare cause of edema. To date, there is no standard of care. The physiopathology of ICE could be explained…”
Get full text